Market Access News | pharmaphorum

News

Chinese patients to get new drugs before UK after Brexit - s...

US, European, Japanese and Chinese patients could get novel medicines ahead of patients in the UK after Brexit, the CEO of French pharma Ipsen has said in an interview.

News

Mylan launches Advair generic at 70% discount in US

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug.

News

NICE launches scientific advice tie-up with Canadian agency

The UK’s cost-effectiveness regulator NICE and the its counterpart in Canada have launched a new collaboration to offer parallel scientific advice to the life sciences industry.

News

Novartis and Lilly CEOs back Trump plans to cut drug prices

CEOs from Novartis and Eli Lilly have backed US government proposals to cut out “middlemen” in the health system, who have inflated the costs of their medicines.

News

Vertex calls for changes to NICE as CF drug profits soar

Vertex has revealed financial figures that are likely to go down well with investors, but not patients in the UK who are eligible to receive the revolutionary drugs like Orkambi yet are bei

News